What men should know about proposed changes for testosterone therapy

The FDA is considering labeling changes for testosterone replacement therapy (TRT) products. While the proposed changes would make TRT much more accessible, the FDA is still advising that use of TRT should be avoided in men with metastatic prostate cancer.